Former Senior Vice President, Strategic Advisor R&D · Theravance Biopharma, Inc. (TBPH)

Richard Graham

A named executive officer of Theravance Biopharma in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,406,333

Salary $518,333Stock awards $753,000

FY2022: $1,066,599

2nd of 3 named executive officers at Theravance Biopharma by FY2023 total.

3 named officers on file for Theravance Biopharma, FY2023

Richard Graham’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Theravance Biopharma’s whole pay program stands against its peers

  • Theravance Biopharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TBPH→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 5, 2024 (DEF 14A).

Free

Get Richard Graham’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Richard Graham compensation by year

Theravance Biopharma Summary Compensation Table · all 2 fiscal years held
In US dollars, as Theravance Biopharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$482,875$518,333
Bonus$291,094$0
Stock awards$0$753,000
Option awards$0$0
Non-equity incentive$287,500$130,000
Pension and deferred compensation$0$0
All other$5,130$5,000
Total$1,066,599$1,406,333

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Theravance Biopharma, Inc. DEF 14A filed April 5, 2024, accession 0001104659-24-044282, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Theravance Biopharma, Inc. filed document, accession 0001104659-24-044282. Every figure is read from that document and cited to the page and table it appears in. Filed April 5, 2024.

$1.1M
$1.4M
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU87,500$983,500—
RSU75,000$843,000—
PSU25,000$281,000—
RSU20,312$228,307—
PSU10,000$112,400—
RSU7,500$84,300—
RSU5,156$57,953—
RSU1,250$14,050—

Per the Outstanding Equity Awards at Fiscal Year-End table in Theravance Biopharma, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Theravance Biopharma’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Rick WinninghamChief Executive Officer$4,318,531
Richard Graham · this pageFormer Senior Vice President, Strategic Advisor R&D$1,406,333
Aziz SawafSenior Vice President, Chief Financial Officer$1,386,700

The full Theravance Biopharma compensation record

free company brief

This page is one person within Theravance Biopharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Theravance Biopharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Graham's compensation dossier · One-time report. No refunds.